SCHEMBL7130620

SCHEMBL7130620

Clc1ccc([CH]/C=C/c2ccc(Br)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
AHR P35869 1/20 0.43
GPR183 P32249 2/20 0.41
CYP1A2 P05177 1/20 0.41
FBP1 P09467 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7121300 1.00 HDAC2 (0.46) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL10422570 0.89 HDAC2 (0.55) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL3668723 0.89 AHR (0.52) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL3851036 0.89 AHR (0.52) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL7129484 0.89 CYP2C19 (0.45) CYP1A2KDM4EALDH1A1HPGDCYP2C19
SCHEMBL1758044 0.84 AHR (0.58) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL1758043 0.84 AHR (0.58) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL3847986 0.81 MAOB (0.54) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL11091721 0.81 MAOB (0.54) HDAC2HDAC3HDAC4HDAC1HDAC7
SCHEMBL3847989 0.81 MAOB (0.54) HDAC2HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6667346-B2 Administration of a radioprotective alpha, beta unsaturated aryl sulfone compound to a patient prior to anticancer radiotherapy reduces cytotoxic side effects of radiation on normal cells TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2003-12-23 US disclosed